The effects of the tri-iodothyronine (T 3 ) secreted by thyroid cells on the growth of the thyrocyte are poorly known. In this study we analyzed the effects of T 3 on the proliferation of bovine thyroid follicles in primary culture previously depleted of endogenous T 3 . Cellular deoxiribonucleic acid (DNA) synthesis, determined by [ 3 H]thymidine incorporation, was stimulated by T 3 (0·1-5·0 nM) for 24 h in a concentration-dependent fashion with a maximal effect at 1·0 nM T 3 (P<0·01). This T 3 action was time-dependent when assayed from 12 to 72 h. The induction of mitogenic activity was corroborated by the increase in proliferating cell nuclear antigen (PCNA) measured by Western blot analysis. PCNA increased after treatment with T 3 (0·1-5·0 nM) in a concentrationdependent manner. Since T 3 modifies the activity of growth factors whose actions are mainly mediated by tyrosine kinase (TK) activation in diverse cellular types, we assayed the effects of genistein, a general TK inhibitor, and tyrphostin A25, a specific epidermal growth factor (EGF)-receptor (EGFR)-dependent TK activity inhibitor, on the proliferative effects of T 3 . The T 3 -induced [ 3 H]thymidine incorporation was inhibited by both agents in a concentration-dependent manner. A significant increase in the total TK activity measured in cellular protein extracts was induced by 0·5 and 1·0 nM T 3 (P<0·001). Tyrosine phosphorylation of the EGFR was also stimulated by T 3 (P<0·001) with no change in the EGFR expression as determined by Western blot analysis. Both, the T 3 -stimulated [
Introduction
Several authors investigated the T 3 effects on thyroid cells with controversial results. It has been reported that thyroid tissue takes up and dehalogenates exogenous thyroid hormone (TH) rapidly (Pisarev 1985) . Other observations indicate that TH can inhibit thyroid cell function both in vivo and in vitro (Juvenal et al. 1981 , Akiguchi et al. 1992 , Spitzweg et al. 1999 . The presence of nuclear T 3 receptors (T 3 R) in thyroid cells from some species has been well established (Erkenbrack & Rosenberg 1986 , Pisarev et al. 1986 , Nakamura & Imura 1988 , Brönnegård et al. 1994 , raising the possibility that T 3 R could participate in the regulation of gene expression by T 3 in thyroid cells.
Previous results indicate that T 3 was able to induce cell proliferation in the rat thyroid cell line FRTL-5 and in benign and malignant thyroid tumors (Akiguchi et al. 1992 , Nagy et al. 1999 . However, the mechanisms involved in the proliferation of these cells probably differ from those in normal thyroid cells, a possibility that emphasizes the interest in the study of the proliferative actions of T 3 on thyroid cells in primary culture. Several growth factors such as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), insulin-like growth factor I (IGF-I) and others, whose actions are mediated by tyrosine kinase (TK) receptors, have been shown to be important for thyroid cell proliferation in all the model systems tested so far (Dumont et al. 1992 , Bidey et al. 1999 . Some of these factors are reported to be involved in thyroid folliculogenesis and goitrogenesis (Nilsson 1995 , Roger et al. 1997 , Bidey et al. 1999 . Moreover, a thyroid hormone-dependent increase in the levels of immunoreactive EGF and EGF-messenger ribonucleic acid (mRNA) in the mouse thyroid gland has been reported, suggesting that T 3 R could modulate the thyroid function through EGF (Osawa et al. 1991 , Sheflin et al. 1993 .
The objective of this study was to examine the actions of T 3 on the proliferation of bovine thyroid cells previously depleted of endogenous T 3 and evaluate the participation of EGF receptor (EGFR) activation in the T 3 effect. T 3 -induced DNA synthesis was demonstrated when cell proliferation was assessed by [ 3 H]thymidine incorporation and corroborated by the expression of the proliferating cell nuclear antigen (PCNA) as a marker of mitotic activity (Iatropoulous & Willams 1996) . Genistein and tyrphostin A25, a general inhibitor of protein tyrosine phosphorylation and an EGFR-specific TK inhibitor, respectively, were used to determine whether tyrosine phosphorylation was involved in the T 3 -induced DNA synthesis. We also aimed to analyze the effect of T 3 on the induction of TK activity, EGFR expression and EGFR tyrosine phosphorylation as well as the action of an anti-EGF antibody on the T 3 -proliferative effect. Our results demonstrated that T 3 acts as a proliferative agent in bovine thyroid cells and support the contention that EGFR-mediated tyrosine phosphorylation may play an important role in T 3 -induced proliferation.
Materials and Methods

Materials
Tritiated thymidine ([methyl-3 H]thymidine), [ 32 P]ATP and the Renaissanse NEL-100 immuno-chemoluminescence kit, were from DuPont NEN (Boston, MA, USA). Human epidermal growth factor (hEGF) was from Calbiochem (La Jolla, CA, USA). Primary sheep polyclonal anti-human EGFR antibody, Dulbecco:Ham F12 (1:1) serum-free tissue culture medium modified by Coon, and Protein TK Assay System were from Gibco BRL (Gaithersburg, MD, USA). Rabbit polyclonal anti-human PCNA (FL-261), and monoclonal mouse anti-phosphotyrosine (PY20) primary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Secondary horseradish peroxidase (HRP)-conjugated rabbit anti-sheep IgG, goat anti-rabbit immunoglobulin G (IgG), and sheep anti-mouse IgG were from Bethyl Labs Inc (Montgomery, TX, USA), DAKO Corp (Denmark) and Sigma Chemical Co (St Louis, MO, USA), respectively. NCS tissue solubilizer and molecular weight markers (33·5-205 kDa) were obtained from Amersham International (Little Chalfont, Bucks, UK). Specific rabbit anti-mouse EGF antibody, not cross-reacting with transforming growth factor (TGF-), and tissue culture grade reagents were purchased from Sigma Chemical Co except where indicated.
Primary culture of bovine thyroid follicles and T 3 depletion
Primary cultures of bovine thyroid cells were obtained according to the protocols described previously (Roger et al. 1986 , Costamagna et al. 1998 ) with modifications. Briefly, bovine thyroid tissues obtained from a local abattoir were digested with collagenase type IV (0·3 mg/ ml), DNase I (5 µg/ml) and CaCl 2 (1·0 mM) for 2 h at 38 C and cultured in suspension. The serum-free culture medium was supplemented with bovine transferrin (5 µg/ ml), insulin (10 µg/ml), glutamine (2 mM), and antibiotics (100 µg/ml streptomycin, 100 U/ml penicillin, 50 µg/ml gentamicin and 2·5 µg/ml amphotericin B). Cells were cultured in a controlled atmosphere of 95% air-5% CO 2 at 37 C. Endogenous T 3 was depleted by changing the culture medium every 24 h for 7 days. T 3 concentration in the culture medium was determined daily by radioimmunoassay (Diagnostic Products Corp, Los Angeles, CA, USA). Agents to be tested were incorporated on day 7 of culture in triplicate dishes for the time indicated. The cell viability, as assessed by the Trypan Blue exclusion test, ranged from 80-90% (Freshney 1987) . H]thymidine and T 3 were added together. Excess radioactivity was eliminated by washing the cells with phosphate-buffered saline (PBS: 9·1 mM NaH 2 PO 4 , 1·7 mM Na 2 HPO 4 , 150 mM NaCl, pH 7·4) and the DNA precipitated by incubation at 4 C for 30 min with 1 vol 20% trichloroacetic acid (TCA). The pellet was washed with 10% TCA, dried at 50 C and dissolved in NCS. Precipitable DNA radiation was measured by scintillation counting and related to DNA content. Total cellular DNA was quantified according to Burton (1956) .
Total cellular protein extract preparation
The expression of PCNA, EGFR and EGFR tyrosine phosphorylation was determined in protein extracts from T 3 -depleted thyroid cells treated with T 3 (0·1-5·0 nM) by Western blot analysis prior to immunoadsorption of PCNA and EGFR with specific antibodies, according to standard procedures (Sambrook et al. 1989) , with modifications. Briefly, thyroid cells were rinsed twice with cold PBS and resuspended in cold lysis buffer (LB: 10 mM HEPES pH 7·4, 1 mM MnCl 2 , 10 mM MgCl 2 , 0·1 mM EGTA, 0·5% Triton X-100) in the presence of protein phosphatase and protease inhibitors (40 mM -glycerol phosphate, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulphonyl fluoride, 5 µg/ml leupeptine, 5 µg/ml aprotinine). Total cellular protein extracts were obtained by successive passages through a syringe and needle, and centrifuged at 13 000 g. The protein content of the supernatant was determined according to Lowry et al. (1951) .
PCNA and EGFR immunoadsorption
PCNA and EGFR were immunoadsorbed by incubating aliquots (200 µg protein) of the extracts for 2 h at 4 C with rabbit polyclonal anti-human recombinant PCNA antibody (1:100) or polyclonal sheep anti-human EGFR antibody (1:750), respectively. The immunocomplexes were recovered from the mixture by incubation with protein G coupled to sepharose 4B overnight at 4 C with gentle agitation and centrifuged at 10 000 g for 10 min.
Determination of expression of PCNA, EGFR and EGFR tyrosine phosphorylation by Western blot analysis
Immunoadsorbed proteins were carefully washed 3 times with cold LB, resuspended in 20 µl Tris-HCl (1 M) pH 6·8 and electrophoresed (Mini-Protean II, Electrophoresis Cell, Bio-Rad) in 7·5-10% polyacrylamide gels with 1% SDS (SDS-PAGE) in parallel with prestained molecular weight markers. Proteins were transferred to a nitrocellulose membrane for 70 min at 100 V in a Trans-Blot cell (Mini Trans-Blot, Electrophoretic Transfer Cell, BioRad). To detect PCNA and EGFR, antibodies at 1:600 and 1:2000 dilution, respectively, were used. Tyrosinephosphorylated EGFR was detected by a primary mouse monoclonal anti-phosphotyrosine antibody (PY20) at 1:500 dilution. Goat anti-rabbit IgG (1:2000), rabbit anti-sheep IgG (1:10 000) and sheep anti-mouse IgG (1:400) were used as HRP-conjugated secondary reagents. The HRP reaction was developed by immunochemoluminiscence. The spots were analyzed and semiquantified densitometrically at 500 nm (Shimadzu Dual-Wavelength Chromato Scanner CS-930).
Tyrosine kinase activity
Aliquots from total cellular protein extracts (5 µg protein) were incubated in 20 µl kinase buffer (30 mM HEPES pH 7·4, 10 mM MgCl 2 , 0·02 mM EDTA, 0·1 mM dithiothreitol (DTT), 0·025 mg/ml BSA, 0·15% v/v Nonidet-P 40, 0·07 mM Na 3 VO 4 , 0·06 mM ATP) in the presence of 0·5 mM specific TK substrate peptide RR-SRC, and 1·0 µCi [ 32 P]ATP (6000 Ci/mmol) at 30 C for 30 min and the reaction was stopped with cold 10% TCA. Aliquots from the supernatant were spotted onto phosphocellulose filters and rinsed twice with 1% acetic acid and twice with water before quantification in a liquid scintillation counter. The results were expressed as pmol P incorporated in 30 min of reaction. Preliminary studies indicated that the reaction was linear from 1 to 15 µg of thyroid protein extracts. Controls for TK activity were run as described previously (Sheffield 1998) . TK activity conducted in the absence of the substrate peptide was <15%, indicating an adequate specificity of the reaction.
Statistical analysis
The analysis of multiple intergroup differences in each experiment was conducted by one-way analysis of variance (ANOVA) followed by Student-Newman-Keuls' test. P<0·05 was considered statistically significant. Except when indicated, all values were obtained from three independent experiments in which at least triplicate samples were assayed.
Results
T 3 depletion from bovine thyroid follicles in primary culture
In order to obtain follicular cells depleted of endogenous T 3 , the culture medium was changed every 24 h for 7 days. Table 1 shows that daily changes of culture medium effectively reduced the total T 3 concentration after 7 days of culture, indicating that the culture system had reached optimal conditions to evaluate the exogenous T 3 action.
Stimulation of [ 3 H]thymidine incorporation and PCNA expression by T 3
Bovine thyroid cell proliferation was determined by measuring the incorporation of [ illustrates the time course effect of 1·0 nM T 3 . Significant stimulation of the [ 3 H]thymidine incorporation was observed at 24 h and longer ( Fig. 2A) . When the values of T 3 -treated thyroid cells at the different exposure times were expressed as a percentage of their control values it was found that the stimulatory effect of T 3 on [ 3 H]thymidine incorporation was significant at 24 and 48 h (Fig. 2B) .
The effect of T 3 on the PCNA expression is depicted in Fig 3. The results obtained indicate that T 3 produced a concentration-dependent increase in the PCNA expression in bovine thyroid cells, a finding that is in line with the T 3 -stimulated [ 3 H]thymidine incorporation.
Absence of an iodide effect on [ 3 H]thymidine incorporation
The role of iodide in thyroid cell proliferation has been widely studied. Although inhibitory effects of iodide are well established, it has been observed that low concentrations of iodide could stimulate thyroid cell proliferation (Pisarev 1985 , Smerdely et al. 1993 . Therefore, we explored whether iodide concentrations that could be generated from the total or partial deiodination of 1·0 nM T 3 , could exert a proliferative effect in our system. 
Inhibition of T 3 -induced [ 3 H]thymidine incorporation by cycloheximide
To investigate the involvement of protein synthesis in the effect of T 3 on [ 3 H]thymidine incorporation, the action of cycloheximide was analyzed. The addition of 1·0 µg/ml cycloheximide significantly inhibited the 1·0 nM T 3 -stimulated [ 3 H]thymidine incorporation, whereas the control value (Fig. 4) or the cell viability (data not shown) were not altered.
Inhibition of T 3 -induced [ 3 H]thymidine incorporation by TK inhibitors
The action of genistein, a general TK inhibitor, and tyrphostin A25, claimed to be an EGFR-specific inhibitor (Levitzky & Gazit 1995 , Partik et al. 1999 , were assayed on the T 3 -induced [ 3 H]thymidine incorporation. Genistein (1-10 µM) reduced the T 3 -stimulated [
3 H]thymidine incorporation in a concentration-dependent fashion (Fig.  5) . A similar concentration-dependent inhibition was exerted by tyrphostin A25 (1-10 µM) (Fig. 6) . Bovine thyroid cells incubated with the highest concentration of genistein or tyrphostin A25 (10 µM) used in the experiments had no effect on cell viability as assessed using the Trypan Blue exclusion test.
Stimulation of total TK activity by T 3
Results from experiments with TK activity inhibitors suggested that TK activity could play some part in the action of T 3 on DNA synthesis. To check this hypothesis we measured the total TK activity in cellular protein extracts from T 3 -depleted bovine thyroid cells treated with different concentrations of T 3 . As shown in Table 2 , a significant increase of the TK activity was observed. The effect was concentration dependent with a maximum at 1·0 nM T 3 . Interestingly, a measurable basal activity was registered in the protein extract.
From the data obtained with tyrphostin A25, a mediation of the EGFR in the TK activation induced by T 3 was suspected. To estimate the involvement of EGFR in the T 3 -increased TK activity, the effect of anti-EGFR antibody was assayed. The T 3 -induced TK activity was progressively reduced by increasing concentrations of the anti-EGFR antibody, suggesting that the TK activity observed in response to T 3 was predominantly due to the EGFR activation (Table 3) .
Effect of T 3 on the expression of EGFR and EGFR-tyrosine phosphorylation
To further investigate the involvement of EGFR in the induction of TK activity and DNA synthesis observed in response to T 3 , changes in EGFR expression were analyzed by Western blotting of the immunoadsorbed EGFR from the protein extract of thyroid follicles treated with T 3 (0·1-5·0 nM) for 24 h. T 3 did not significantly modify the level of expression of the EGFR in the concentration range previously demonstrated to stimulate [ 3 H]thymidine incorporation and total TK activity.
The influence of T 3 on EGFR-tyrosine phosphorylation was examined by Western blotting using antiphosphotyrosine (PY20) as primary antibody. Figure 7 depicts the results obtained indicating that increasing concentrations of T 3 induced a progressive increment in the tyrosine phosphorylation of the EGFR that was significant at all the T 3 concentrations tested.
Inhibition of the T 3 -induced [ 3 H]thymidine incorporation by anti-EGF antibody
To check for possible participation of EGF in the T 3 -induced DNA synthesis, we explored whether the T 3 -stimulated [ 3 H]thymidine incorporation was antagonized by an anti-EGF antibody. The antibody anti-EGF was able to significantly diminish the [ 3 H]thymidine incorporation induced by 1·0 nM T 3 as a function of the dilutions of anti-EGF tested (Fig. 8) . The antibody dilutions used were also able to attenuate the [ 3 H]thymidine incorporation in the control cells, indicating a basal activity of the growth factor.
To corroborate the ability of thyroid follicles to respond to an exogenous EGF stimulation, the effect of human EGF on the [ were: control, 1394 143; T 3 (1·0 nM), 2674 284*; EGF (100 ng/ml), 2443 180* (*P<0·001 vs control).
Discussion
The presence of T 3 R and diverse T 3 actions in thyrocytes from different species (Pisarev 1985 , Erkenbrack & Rosenberg 1986 , Pisarev et al. 1986 , Nakamura & Imura 1988 , Akiguchi et al. 1992 , Brönnegård et al. 1994 , Nagy et al. 1999 ) support the argument that the thyroid gland is a target for T 3 . Recent findings in transgenic animals suggest that T 3 R play an important role in the development and growth of the thyroid gland (Gauthier et al. 1999) . Some preliminary studies evaluating the potential role of TH in the thyroid follicular cell function were limited because of the high levels of endogenous T 3 in the thyroid cell that mask the effect of exogenous T 3 (Nakamura & Imura 1988 , Akiguchi et al. 1992 , Bidey et al. 1999 . Coincidentally, in initial experiments analysing the effect of T 3 on the thymidine incorporation in non-T 3 -depleted bovine thyroid follicles we obtained highly variable results including absence of response (observations not published). Therefore, we attempted an approach in which the endogenous T 3 level was maximally reduced leaving the culture system responsive to exogenous T 3 .
The effect of TH on the growth regulation in the thyrocyte is not known (Bidey et al. 1999) . Our results support the notion that T 3 could act as a thyroidal growth factor since a T 3 -induced increase of thymidine incorporation was demonstrated. Furthermore, in our experiments the proliferative effect of T 3 was sustained by PCNA expression, a reliable marker to test cell proliferation (Bravo et al. 1987 , Iatropoulous & Willams 1996 . The concentration-response curve of PCNA expression by T 3 was similar to that of thymidine incorporation although they diverged at 5·0 nM T 3 , indicating that additional mechanisms could be involved in the response of the two proliferation indexes at high T 3 concentrations.
It is known that iodide leads either to growth inhibition or induction in thyroid tissue, depending on the type of cell and the culture system (Pisarev 1985 , Smerdely et al. 1993 . Since an activation of the thyroidal type I 5 -deiodinase by T 3 has been observed (Mori et al. 1996) , an implication of iodide in the cellular growth response to T 3 should not be discarded. However, most of the T 3 effects on the thyroid tissue do not seem to be due to its deiodination (Pisarev 1985) although slight dehalogenation of T 3 have been reported in calf thyroid slices (Juvenal et al. 1981) . In agreement, iodide concentrations within the range expected to be generated from total or partial T 3 deiodination did not modify basal thymidine incorporation in our system, supporting the idea that iodide is not involved in the T 3 -induced DNA synthesis.
It is known that the effect of TH is exerted mainly by the regulation of gene expression mediated by T 3 R. However, it has been demonstrated that T 3 has also non-genomic actions which are rapid and not inhibited by cycloheximide (Davis & Davis 1996 , Wehling 1997 , Lin et al. 1999 . In our system the inhibition of the T 3 -stimulated thymidine incorporation by cycloheximide indicates the possible mediation of protein synthesis. This effect is in accordance with a genomic action and supported by the observation of the maximal proliferative effect at 1·0 nM T 3 , a concentration very similar to the apparent K d of the nuclear binding sites (Akiguchi et al. 1992) . However, these findings do not exclude possible non-genomic actions of T 3 on signal transduction pathways. Evidence for a close functional relationship between TH and EGF in the regulation of cellular growth has been obtained in various cellular types (Hinkle & Kinsella 1986 , Walker 1986 , Kaji & Hinkle 1987 , Matsuo et al. 1993 . Most of the cellular proliferative responses to growth factors are mediated by TK activity (Sibley et al. 1988 , Dumont et al. 1992 . The blockage of the T 3 -induced DNA synthesis by TK inhibitors indicated a participation of TK activity in the T 3 action. Interestingly, genistein was reported as a potent antiproliferative agent in thyroid cancer cell lines (Yin et al. 1999) . The involvement of TK activity in the proliferative effect of T 3 was further confirmed by the T 3 -induced increase of the total TK activity. The abolishment of the T 3 -induced DNA synthesis by tyrphostin A25 was in favor of an EGFRmediated TK activity in the T 3 -stimulated proliferation. This hypothesis was further confirmed by the inhibition of the T 3 -induced TK activity in the presence of an anti-EGFR antibody.
Changes in the EGFR expression by TH have been documented in vivo as well as in cultured cells of some species (Fisher & Lakshmanan 1990 , Nilsson 1995 but not in thyroid cells. Variations in EGFR levels seem not to be involved in the proliferative effect of T 3 in our system since no changes in the EGFR expression were detected after T 3 exposure. It is known that the ligand-induced TK activity of the EGFR leads to the tyrosine autophosphorylation of the receptor as a previous step in the signal transduction cascade (Chen et al. 1987) . We demonstrated a stimulatory effect of T 3 on the expression of EGFRtyrosine phosphorylation thus evidencing an activation of the EGFR. The T 3 -dependent increase in the EGFRtyrosine phosphorylation paralleled the increase in total TK activity and DNA synthesis although the persistence of high levels of tyrosine-phosphorylated EGFR was not correlated with the lack of increase in the total TK activity and thymidine incorporation at 5·0 nM T 3 . This may indicate the involvement of some other factors in the diminution of TK activity at this T 3 concentration. In accordance, several reports demonstrated that the EGFR activation also resulted in the phosphorylation of EGFR on threonine residues, leading to receptor internalization or TK activity inhibition (Sibley et al. 1988 ). This biphasic T 3 effect on DNA synthesis may also be a consequence of the T 3 deiodination (Mori et al. 1996) or the phosphorylation of multiple proteins including the T 3 R, an event reported to play a role in regulating the action of T 3 R as well as other nuclear hormone receptors (Sugawara et al. 1994 , Solomon et al. 1999 . A TH-dependent increase in the level of EGF mRNA and immunoreactive EGF in the mouse thyroid tissue has been reported (Osawa et al. 1991 , Sheflin et al. 1993 . Our findings support the notion that an EGF/EGFR activation could mediate the proliferative response to T 3 by the demonstration of a T 3 -induced DNA synthesis along with an EGFR-associated TK activity. The inhibition of the T 3 -induced thymidine incorporation by an anti-EGF antibody favors this hypothesis.
Previous evidence indicates that T 3 exerts mainly inhibitory effects on several thyrotropin (TSH)-stimulated functional parameters in the thyroid (Pisarev 1985) . Recently, in FRTL-5 cells it was observed that T 3 attenuated the expression of the sodium iodide symporter (Spitzweg et al. 1999) . By coincidence, EGF is a strong inhibitor of thyroid function in several species, as well as a potent proliferative agent (Fisher & Lakshmanan 1990 , Nilsson 1995 . Therefore, the possibility that the inhibitory effect of T 3 on thyroid function could be mediated by an autocrine action of EGF as we propose for the T 3 -proliferative effect should be addressed.
It is widely accepted that the administration of TH inhibits thyroid function and growth by suppressing TSH release (Utiger 1995) . We believe that the contribution of TH on the thyroid gland proliferation should be considered as an additional regulatory pathway. It is possible to speculate that TH participates in a short-loop feedback mechanism in concert with EGF to modulate thyroid function. Thus, in the thyrocyte T 3 might induce the biosynthesis and release of EGF and in turn, EGF could diminish the biosynthesis of TH. The T 3 proliferative action on the thyroid cell seems to operate better at T 3 concentrations closer to the affinity constant value of the T 3 R and poorly at high T 3 levels. This could be regarded as a protective mechanism of the thyroid cell against the exposition to large amounts of TH. A lack of control of this mechanism could result in unregulated thyroid cell growth. Hence, a T 3 -induced proliferation could be involved in the goiter induction that occurs in patients with mild TH deficiency (Utiger 1995) as well as in the TH resistance syndrome (Weiss & Reffetof 1997) . In these entities the relatively insufficient T 3 activity could render the thyroid cell more sensitive to the T 3 proliferative effect.
Taken together, these results indicate that T 3 is a potential proliferative agent in the thyroid cell by a mechanism that involves, at least in part, an EGFRmediated TK activation by the enhanced expression, availability or actions of autocrine EGF. The physiological and clinical relevance of the relationship between T 3 and EGF in the thyroid tissue remains to be determined. P<0·01 and ♦♦ P<0·001 vs T 3 (1·0 nM).
